CG
ASLN

Cutler Group’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Cutler Group’s Portfolio ASLN Stock Details ASLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$0 Sell
113
-12
-10% -$60 ﹤0.01% 3911
2023
Q4 		$0 Buy
+125
New +$943 ﹤0.01% 4533
2022
Q2 		– Sell
-3
Closed – – 5874
2022
Q1 		$0 Hold
3
– – ﹤0.01% 6258
2021
Q4 		$0 Sell
3
-97
-97% -$5.82K ﹤0.01% 6317
2021
Q3 		$7K Buy
+100
New +$11.4K ﹤0.01% 4272

Other funds holding ASLN

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Cutler Group's ASLN Position: Q1 2024 in Review

Cutler Group reduced its ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) stake by 9.6% in Q1 2024, selling an estimated $60 and leaving 113 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #3911.

Cutler Group first reported a position in ASLN in Q3 2021 and has held it in 5 quarters since. The position peaked at $7K in Q3 2021. 22 funds tracked by Wall St. Rank hold ASLN as of Q1 2024.

  • Cutler Group held 113 shares of ASLAN Pharmaceuticals Limited American Depositary Shares worth $0 as of Q1 2024.
  • Cutler Group sold 12 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q1 2024, an estimated $60.
  • ASLAN Pharmaceuticals Limited American Depositary Shares made up ﹤0.01% of Cutler Group's portfolio in Q1 2024, its #3911 holding.
  • Cutler Group first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q3 2021 and has held it in 5 quarters since.
  • Cutler Group's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $7K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.